share_log

8-K: Current report

8-K: Current report

8-K：重大事件
美股SEC公告 ·  06/15 02:45

牛牛AI助理已提取核心訊息

On June 10, 2024, FOXO Technologies Inc., a biotechnology company listed on the NYSE American under the ticker FOXO, received a notice from NYSE Regulation indicating noncompliance with continued listing standards due to unpaid listing fees overdue by more than 180 days. The company had until June 7, 2024, to make the payment to avoid noncompliance procedures but failed to do so. FOXO Technologies must now submit a written plan by June 17, 2024, detailing how it will settle the outstanding fees within 30 days. Failure to provide a satisfactory plan or to make progress on the payment as accepted by NYSE may lead to delisting proceedings. The company has confirmed receipt of the notice and intends to present a compliance plan to regain compliance with NYSE American listing standards. On June 14, 2024, FOXO Technologies issued a press release regarding the notice and reaffirmed its commitment to resolving the delinquency and regaining compliance. The press release also mentioned planned acquisitions intended to improve cash flow and financial stability.
On June 10, 2024, FOXO Technologies Inc., a biotechnology company listed on the NYSE American under the ticker FOXO, received a notice from NYSE Regulation indicating noncompliance with continued listing standards due to unpaid listing fees overdue by more than 180 days. The company had until June 7, 2024, to make the payment to avoid noncompliance procedures but failed to do so. FOXO Technologies must now submit a written plan by June 17, 2024, detailing how it will settle the outstanding fees within 30 days. Failure to provide a satisfactory plan or to make progress on the payment as accepted by NYSE may lead to delisting proceedings. The company has confirmed receipt of the notice and intends to present a compliance plan to regain compliance with NYSE American listing standards. On June 14, 2024, FOXO Technologies issued a press release regarding the notice and reaffirmed its commitment to resolving the delinquency and regaining compliance. The press release also mentioned planned acquisitions intended to improve cash flow and financial stability.
2024年6月10日，紐交所逐筆明細爲FOXO的生物技術公司FOXO Technologies Inc.收到了來自紐交所監管部門的通知，指出由於逾期180天以上未支付上市費用，未符合繼續上市標準，公司最遲於2024年6月7日支付，以避免違規程序，但未能如期付款。FOXO Technologies現在必須在2024年6月17日之前提交一份書面計劃，詳細說明如何在30天內清算未償還費用。未能提供令人滿意的計劃或未能根據紐交所接受的計劃付款可能導致退市程序。公司已確認收到通知並有意提出符合紐交所美國上市標準的合規計劃。2024年6月14日，FOXO Technologies發表了一份關於通知的新聞稿，重申其解決拖欠款項並恢復合規的承諾。新聞稿還提到了擬議中的收購，旨在改善現金流和財務穩定性。
2024年6月10日，紐交所逐筆明細爲FOXO的生物技術公司FOXO Technologies Inc.收到了來自紐交所監管部門的通知，指出由於逾期180天以上未支付上市費用，未符合繼續上市標準，公司最遲於2024年6月7日支付，以避免違規程序，但未能如期付款。FOXO Technologies現在必須在2024年6月17日之前提交一份書面計劃，詳細說明如何在30天內清算未償還費用。未能提供令人滿意的計劃或未能根據紐交所接受的計劃付款可能導致退市程序。公司已確認收到通知並有意提出符合紐交所美國上市標準的合規計劃。2024年6月14日，FOXO Technologies發表了一份關於通知的新聞稿，重申其解決拖欠款項並恢復合規的承諾。新聞稿還提到了擬議中的收購，旨在改善現金流和財務穩定性。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間